Lipid binding protein (apolipoprotein A-I) contamination of high grade commercial albumins.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 570127)

Published in FEBS Lett on January 01, 1979

Authors

M Fainaru, R J Deckelbaum

Articles by these authors

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet (2000) 6.19

Behçet's disease. Report of 41 cases and a review of the literature. Medicine (Baltimore) (1975) 5.68

AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation (2000) 4.80

Parents as the exclusive agents of change in the treatment of childhood obesity. Am J Clin Nutr (1998) 2.49

HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia. Nat Med (2001) 2.14

Dietary guidelines for healthy American adults. A statement for health professionals from the Nutrition Committee, American Heart Association. Circulation (1996) 1.91

AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Stroke (2000) 1.90

Sterol esterification in yeast: a two-gene process. Science (1996) 1.74

Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein. J Biol Chem (1998) 1.73

Thermal transitions in human plasma low density lipoproteins. Science (1975) 1.72

Loci for CETP, LPL, LIPC, and APOC3 affect plasma lipoprotein size and sub-population distribution in Hispanic and non-Hispanic white subjects: the Columbia University BioMarkers Study. Nutr Metab Cardiovasc Dis (2002) 1.61

Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol-fed dogs and from humans with type III hyperlipoproteinemia. J Lipid Res (1982) 1.57

Use of serum amylase isoenzymes in evaluation of pancreatic function. Pediatrics (1974) 1.57

Structure and interactions of lipids in human plasma low density lipoproteins. J Biol Chem (1977) 1.55

Composition of proteins of mesenteric lymph chylomicrons in the rat and alterations produced upon exposure of chylomicrons to blood serum and serum proteins. J Lipid Res (1978) 1.48

"Early" vs. "late" diagnosis of celiac disease in two ethnic groups living in the same geographic area. Isr J Med Sci (1994) 1.48

Hypobetalipoproteinemia due to an apolipoprotein B gene exon 21 deletion derived by Alu-Alu recombination. J Biol Chem (1989) 1.47

The removal of cholesterol from aortic smooth muscle cells in culture and Landschutz ascites cells by fractions of human high-density apolipoprotein. Biochim Biophys Acta (1975) 1.46

Summary of a scientific conference on preventive nutrition: pediatrics to geriatrics. Circulation (1999) 1.46

Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis. J Lipid Res (1985) 1.40

Family history of early cardiovascular disease in children with moderate to severe hypercholesterolemia: relationship to lipoprotein (a) and low-density lipoprotein cholesterol levels. J Lab Clin Med (1999) 1.40

Cryopreservation with sucrose maintains normal physical and biological properties of human plasma low density lipoproteins. J Lipid Res (1992) 1.34

Radioimmunoassay of arginine-rich apolipoprotein of rat serum. Biochim Biophys Acta (1977) 1.32

Prevalence of intestinal infections caused by diarrheagenic Escherichia coli in Bedouin infants and young children in Southern Israel. Pediatr Infect Dis J (1998) 1.31

Lipoprotein lipase hydrolysis of retinyl ester. Possible implications for retinoid uptake by cells. J Biol Chem (1994) 1.31

Structure of human plasma low-density lipoproteins: molecular organization of the central core. Proc Natl Acad Sci U S A (1977) 1.30

Structure and thermodynamic properties of high density lipoprotein recombinants. J Biol Chem (1977) 1.28

Role of behaviour modification in the treatment of childhood obesity with the parents as the exclusive agents of change. Int J Obes Relat Metab Disord (1998) 1.27

Visualization of virus-like particles in endoplasmic reticulum of hepatocytes of Australia antigen carriers. Lab Invest (1972) 1.23

Cryptosporidium, malnutrition, and chronic diarrhea in children. Am J Dis Child (1988) 1.22

Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport. Proc Natl Acad Sci U S A (1990) 1.21

Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. J Clin Invest (1992) 1.20

Reversible modification of human plasma low density lipoproteins toward triglyceride-rich precursors. A mechanism for losing excess cholesterol esters. J Biol Chem (1982) 1.19

Lipoprotein lipase expression level influences tissue clearance of chylomicron retinyl ester. J Lipid Res (1999) 1.17

Guidelines for exercise testing in the pediatric age group. From the Committee on Atherosclerosis and Hypertension in Children, Council on Cardiovascular Disease in the Young, the American Heart Association. Circulation (1994) 1.15

Duplication of the gallbladder associated with childhood obstructive biliary disease and biliary cirrhosis. Gastroenterology (1983) 1.13

Greater dietary intake of simple carbohydrate is associated with lower concentrations of high-density-lipoprotein cholesterol in hypercholesterolemic children. Am J Clin Nutr (1998) 1.12

Apoprotein content of plasma lipoproteins of the rat separated by gel chromatography or ultracentrifugation. Biochem Med (1977) 1.11

Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity. J Lipid Res (1998) 1.11

Radioimmunoassay of human high density lipoprotein apo-protein A-1. Biochim Biophys Acta (1975) 1.10

Human plasma LDL cryopreserved with sucrose maintains in vivo kinetics indistinguishable from freshly isolated human LDL in cynomolgus monkeys. J Lipid Res (1994) 1.10

Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment. J Clin Invest (1984) 1.10

Characterization of a cDNA encoding a cysteine-rich cell surface protein located in the flagellar pocket of the protozoan Trypanosoma brucei. Mol Cell Biol (1990) 1.10

Asymptomatic giardiasis in children. Pediatr Infect Dis J (1989) 1.09

Lipoprotein lipase-mediated selective uptake from low density lipoprotein requires cell surface proteoglycans and is independent of scavenger receptor class B type 1. J Biol Chem (2000) 1.08

Giardia lamblia: identification of different strains from man. Z Parasitenkd (1986) 1.07

Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. J Biol Chem (1994) 1.07

Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis (1984) 1.06

Peptic ulcer disease: a clinical study in 73 children. Can Med Assoc J (1974) 1.05

Temporal arteritis in Israel. A review of 47 patients. J Rheumatol (1979) 1.04

Differential modulation of ACAT1 and ACAT2 transcription and activity by long chain free fatty acids in cultured cells. Biochemistry (2001) 1.04

Radioimmunoassay of apolipoprotein A-I of rat serum. Biochim Biophys Acta (1976) 1.04

Chylomicron-chylomicron remnant clearance by liver and bone marrow in rabbits. Factors that modify tissue-specific uptake. J Biol Chem (1989) 1.04

Malabsorption, hypocholesterolemia, and fat-filled enterocytes with increased intestinal apoprotein B. Chylomicron retention disease. Gastroenterology (1987) 1.02

Secretion of the arginine-rich and A-I apolipoproteins by the isolated perfused rat liver. J Lipid Res (1977) 1.02

n-3 Fatty acids and cardiovascular disease: actions and molecular mechanisms. Prostaglandins Leukot Essent Fatty Acids (2007) 1.02

Combined vitamin A and E therapy prevents retinal electrophysiological deterioration in abetalipoproteinaemia. Br J Ophthalmol (1982) 1.01

Apoprotein synthesis by human duodenojejunal mucosa. Gastroenterology (1978) 1.01

Response to diet and cholestyramine in a patient with sitosterolemia. Pediatrics (1990) 1.01

Natural history of Giardia lamblia and Cryptosporidium infections in a cohort of Israeli Bedouin infants: a study of a population in transition. Am J Trop Med Hyg (1997) 1.01

Revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. J Nutr (2001) 1.01

Thermal behavior of human plasma high density lipoprotein. Biochim Biophys Acta (1977) 1.01

Giardia lamblia carriage in Israeli Bedouin infants: risk factors and consequences. Clin Infect Dis (2000) 1.01

Integrated cardiovascular health promotion in childhood. A statement for health professionals from the Subcommittee on Atherosclerosis and Hypertension in Childhood of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation (1992) 0.99

Cellular differences in lipoprotein lipase-mediated uptake of low density lipoproteins. J Biol Chem (1994) 0.99

Origin and transport of the A-I and arginine-rich apolipoproteins in mesenteric lymph of rats. J Lipid Res (1978) 0.98

Oleate and other long chain fatty acids stimulate low density lipoprotein receptor activity by enhancing acyl coenzyme A:cholesterol acyltransferase activity and altering intracellular regulatory cholesterol pools in cultured cells. J Biol Chem (1995) 0.97

Platelet function in a case with abetalipoproteinemia. Atherosclerosis (1985) 0.97

Behçet's disease with decreased fibrinolysis and superior vena caval occlusion. Br Med J (1973) 0.96

Investigation of human giardiasis by karyotype analysis. J Clin Invest (1992) 0.94

Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma. J Clin Invest (1989) 0.94

Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis. Kidney Int (1999) 0.93

An independent, inverse association of high-density-lipoprotein-cholesterol concentration with nonadipose body mass. Am J Clin Nutr (1999) 0.93

N-3 vs. saturated fatty acids: effects on the arterial wall. Prostaglandins Leukot Essent Fatty Acids (2010) 0.92

Effects of apoprotein E on intracellular metabolism of model triglyceride-rich particles are distinct from effects on cell particle uptake. J Biol Chem (1995) 0.92

Evidence that a separate particle containing B-apoprotein is present in high-density lipoproteins from perfused rat liver. Metabolism (1977) 0.91

Failure of complete bile diversion and oral bile acid therapy in the treatment of homozygous familial hypercholesterolemia. N Engl J Med (1977) 0.91

Cryptosporidium infection in Bedouin infants assessed by prospective evaluation of anticryptosporidial antibodies and stool examination. Am J Epidemiol (2001) 0.91

Apolipoprotein E inhibits serum-stimulated cell proliferation and enhances serum-independent cell proliferation. J Biol Chem (2001) 0.90

Temperature-dependent 13C nuclear magnetic resonance studies of human serum low density lipoproteins. Biochemistry (1976) 0.90

In vitro production of human plasma low density lipoprotein-like particles. A model for very low density lipoprotein catabolism. J Biol Chem (1979) 0.90

Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations. Biochemistry (1997) 0.89

Hypolipidemic effect of beta, beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in normal and nephrotic rats. J Lipid Res (1988) 0.89

Lipid oxidation in unfractionated serum and plasma. Chem Phys Lipids (1998) 0.89

AHA Science Advisory. Stanol/sterol ester-containing foods and blood cholesterol levels. A statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation (2001) 0.88

Unesterified fatty acids inhibit the binding of low density lipoproteins to the human fibroblast low density lipoprotein receptor. J Biol Chem (1989) 0.88

Insulin resistance in obesity: body-weight or energy balance? J Endocrinol (2001) 0.88

Infant dumping syndrome after gastroesophageal reflux surgery. J Pediatr (1981) 0.88

A dose-response study of the effects of dietary cholesterol on fasting and postprandial lipid and lipoprotein metabolism in healthy young men. Arterioscler Thromb (1994) 0.88

Persistent diarrhea in a cohort of Israeli Bedouin infants: role of enteric pathogens and family and environmental factors. J Infect Dis (1998) 0.87

Recent developments in lipid emulsions: relevance to intensive care. Nutrition (1997) 0.87

Virus-like particles in cytoplasm of livers of Au-antigen carriers. Lancet (1971) 0.87

Poverty and cardiac disease in children. Am J Dis Child (1991) 0.87

Hepatic fibrosis, polycystic kidney, colobomata and encephalopathy in siblings. Clin Genet (1974) 0.86

Impact of treatment for childhood obesity on parental risk factors for cardiovascular disease. Prev Med (1999) 0.86

Weight gain and insulin resistance during nicotine replacement therapy. Clin Cardiol (1999) 0.86

Conversion of human plasma high density lipoprotein-2 to high density lipoprotein-3. Roles of neutral lipid exchange and triglyceride lipases. J Biol Chem (1986) 0.86

Endogenously expressed apolipoprotein E has different effects on cell lipid metabolism as compared to exogenous apolipoprotein E carried on triglyceride-rich particles. Biochemistry (2000) 0.86